Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Falchook, Gerald S
253  Ergebnisse:
Personensuche X
?
1

Sotorasib with panitumumab in chemotherapy-refractory KRASG..:

Kuboki, Yasutoshi ; Fakih, Marwan ; Strickler, John...
Nature Medicine.  30 (2024)  1 - p. 265-270 , 2024
Link: https://doi.org/10.1038/..
 
?
2

T cell Immunoglobulin and Mucin Domain Containing Protein 3..:

Duong, Benjamin ; Banskota, Pratyush ; Falchook, Gerald S.
Journal of Immunotherapy and Precision Oncology.  7 (2024)  2 - p. 89-96 , 2024
Link: https://doi.org/10.36401..
 
?
3

B7-H3 Inhibitors in Oncology Clinical Trials: A Review:

Feustel, Kavanya ; Martin, Jared ; Falchook, Gerald S.
Journal of Immunotherapy and Precision Oncology.  7 (2024)  1 - p. 53-66 , 2024
Link: https://doi.org/10.36401..
 
?
4

A phase 2 study of AZD4635 in combination with durvalumab o..:

Falchook, Gerald S. ; Reeves, James ; Gandhi, Sunil...
Cancer Immunology, Immunotherapy.  73 (2024)  4 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
5

A phase 1/2a safety, pharmacokinetics, and efficacy study o..:

Janku, Filip ; Javle, Milind M. ; Sen, Shiraj...
Cancer.  129 (2023)  10 - p. 1537-1546 , 2023
Link: https://doi.org/10.1002/..
 
?
6

A dose escalation/expansion study evaluating dose, safety, ..:

Dasari, Arvind ; Hamilton, Erika P. ; Falchook, Gerald S....
Investigational New Drugs.  41 (2023)  3 - p. 421-430 , 2023
Link: https://doi.org/10.1007/..
 
?
7

A phase Ib study of adavosertib, a selective Wee1 inhibitor..:

Falchook, Gerald S ; Sachdev, Jasgit ; Imedio, Esteban Rodrigo...
Investigational New Drugs.  41 (2023)  3 - p. 493-502 , 2023
Link: https://doi.org/10.1007/..
 
?
8

Long-Term Benefit of Sotorasib in Patients With KRAS G12C–M..:

Dy, Grace K ; Govindan, Ramaswamy ; Velcheti, Vamsidhar...
Future Oncology.  20 (2023)  3 - p. 113-120 , 2023
Link: https://doi.org/10.2217/..
 
?
9

Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Ad..:

Lim, Emerson A. ; Bendell, Johanna C. ; Falchook, Gerald S....
Clinical Cancer Research.  28 (2022)  22 - p. 4871-4884 , 2022
Link: https://doi.org/10.1158/..
 
?
10

Correction: Phase I Trial of ALRN-6924, a Dual Inhibitor of..:

Saleh, Mansoor N. ; Patel, Manish R. ; Bauer, Todd M....
Clinical Cancer Research.  28 (2022)  2 - p. 429-429 , 2022
Link: https://doi.org/10.1158/..
 
?
11

Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors in ..:

Feustel, Kavanya ; Falchook, Gerald S.
Journal of Immunotherapy and Precision Oncology.  5 (2022)  3 - p. 58-67 , 2022
Link: https://doi.org/10.36401..
 
?
12

Phase 1/2 study of epacadostat in combination with durvalum..:

Naing, Aung ; Algazi, Alain P. ; Falchook, Gerald S....
Cancer.  129 (2022)  1 - p. 71-81 , 2022
Link: https://doi.org/10.1002/..
 
?
13

First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist ..:

Yap, Timothy A. ; Gainor, Justin F. ; Callahan, Margaret K....
Clinical Cancer Research.  28 (2022)  17 - p. 3695-3708 , 2022
Link: https://doi.org/10.1158/..
 
?
14

A phase 2 trial of trifluridine/tipiracil plus nivolumab in..:

Patel, Manish R. ; Falchook, Gerald S. ; Hamada, Kensuke..
Cancer Medicine.  10 (2021)  4 - p. 1183-1190 , 2021
Link: https://doi.org/10.1002/..
 
?
15

Translational pharmacokinetic‐pharmacodynamic modeling of p..:

Xiong, Wenyuan ; Friese‐Hamim, Manja ; Johne, Andreas...
CPT: Pharmacometrics & Systems Pharmacology.  10 (2021)  5 - p. 428-440 , 2021
Link: https://doi.org/10.1002/..
 
1-15